The downregulation of the EGFR protein may also affect the pro-oncogenic roles of mitochondrial and nuclear EGFR involved in resistance to apoptosis inducers and EGFR-targeted inhibitors in GBM [101]. The gene discussed is EGFR; the disease is glioblastoma.